Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses
2004; Elsevier BV; Volume: 105; Issue: 1 Linguagem: Inglês
10.1182/blood-2004-01-0298
ISSN1528-0020
AutoresDonald Milligan, Savio Fernandes, Ranjit Dasgupta, Faith E. Davies, Estella Matutes, Chris Fegan, Christopher C. McConkey, J. A. Child, David Cunningham, Gareth J. Morgan, Daniel Catovsky,
Tópico(s)Lymphoma Diagnosis and Treatment
Referência(s)